Microfluidic Devices Market was Led by the Polymer Category

NEW YORK - April 4, 2024 - PRLog -- The size of the microfluidic devices market will grow at a compound annual growth rate of 17.3% by the end of this decade to touch a value of USD 59,785.3 million by 2030.

Microfluidics is a developing scientific field with various logical applications and commercial predictions in the fields of cell biology research, protein crystallization, and medicine. Therefore, this tech is a significant tool to decrease side-effects and advance the effectiveness of treatments.

Furthermore, the requirement for micromachined organic instruments will power considerably in the years to come, powered by the development of genomics and proteomics research, along with the targeted incorporation of lab-on-a-chip tools into lab procedures.

The polymer category led the industry, with a share of about 60%, in 2021. Amongst other polymers, polymer has observed a substantial surge in application, particularly in the rapid prototyping of microfluidic devices, credited to the material's ease of construction into products and low cost. Also, novel surface modifications are introduced to resolve the challenges posed by the hydrophobicity of polymers.

Glass followed the polymer category in the past, and it will grow at a rate of about 18%.  Most of the analytical applications that make use of the glass-based apparatus are dependent on high temperatures and organic solvents. Glass is a formless substance with optical transparency and electric insulation.

North America led the microfluidic devices market with a share of about 40%, in the past, and this domination will continue in the years to come as well, because of the fast acceptance of pioneering techs by the region's key users. Also, the rising research and development activities and the existence of key players will fuel the development, particularly in the U.S.

Explore the Microfluidic Devices Market: https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market

The microfluidic system has arisen as one of the utmost-attractive platforms in the diagnostics field. So, the elderly populace, increasing health and wellness consciousness, growing occurrence of long-lasting and lifestyle-associated ailments, obtainability of favorable insurance options, and tech progressions power the regional acceptance of this diagnostic method.

In the APAC, China is among the fastest-growing for microfluidics as a result of the growing funding of the government and improving healthcare amenities. Consequently, APAC will emerge as an striking market for companies manufacturing these kinds of medical instruments.

Though, in Europe, the industry is powered by the growing diagnosis requirements, credited to the improving healthcare amenities and the growing occurrence of ailments; itself as a result of the lifestyle changes and elderly population.

SOURCE: P&S Intelligence